```

[Federal Register Volume 89, Number 231 (Monday, December 2, 2024)]
[Notices]
[Pages 95237-95238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28196]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Customer Experience Hub

    Notice is hereby given that, on October 1, 2024, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), The Customer Experience Hub 
(``CX Hub'') has filed written notifications simultaneously with the 
Attorney General and the

[[Page 95238]]

Federal Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances.
    Specifically, Alethium Technologies, Inc., West Hollywood, CA; 
Alliance for Cancer Gene Therapy, Inc., Stamford, CT; Aret[eacute] 
Associates, Northridge, CA; Arsenal Medical, Inc., Waltham, MA; ASC 
Biosciences, Inc., Scottsdale, AZ; Association of University Research 
Parks Bio Health Caucus, College Park, MD; Barrow Wise Consulting LLC, 
Rockville, MD; Baylor College of Medicine, Houston, TX; Bio-Tech 
Pharmacal, Inc., Fayetteville, AR; BLEN, Inc., Washington, DC; Boise 
State University, Boise, ID; Caelum Diagnostic Solutions, Inc., Marina 
Del Rey, CA; Care+ Ventures LLC dba Naveon, Baton Rouge, LA; Clinical 
Data Interchange Standards Consortium, Inc., Austin, TX; 
CommunicateHealth, Inc., Rockville, MD; Community Health Design Corps 
LLC, Nashua, NH; Curavit Clinical Research Corp., Scarsdale, NY; Darena 
Solutions LLC, Chesterfield, MO; Eggschain, Inc., Austin, TX; Evernorth 
Health Services, Morris Plains, NJ; Exagen, Inc., Vista, CA; Femovate 
by Guidea, Austin, TX; FemTechnology, Inc., Middletown, DE; Florida 
State University, Tallahassee, FL; Gigantest, Inc., Baltimore, MD; Good 
Days, Frisco, TX; Health Evolve Technologies LLC, Columbia, SC; Health 
Tech Alley, Inc., Columbia, MD; Icarus Therapeutics, San Diego, CA; ICF 
Incorporated LLC, Reston, VA; Ignite Health, Houston, TX; Imaginostics, 
Orlando, FL; Imago Rehab, Inc., Lowell, MA; Immersion, Phoenix, AZ; 
InsiteOne LLC, Wallingford, CT; InvivoSciences, Inc., Madison, WI; 
JEEVA Clinical Trials, Inc., Manassas, VA; Kaiser Foundation Research 
Institute, Oakland, CA; Langrand and Company LLC, Houston, TX; Leva 
LLC, Westwood Hills, KS; LexisNexis Risk Solutions, Inc., Alpharetta, 
GA; MD Health Pathways, Dallas, TX; MedeAnalytics, Inc., Richardson, 
TX; MediPro Direct, Salt Lake City, UT; MentalHappy, Inc., San 
Francisco, CA; Metis Foundation, San Antonio, TX; Mike A. Myers Stroke 
Center, Dallas, TX; Minerva Medical Consulting LLC dba Menrva, Dallas, 
TX; MyHealth.Us, New York, NY; NanoMood Technologies LLC, La Jolla, CA; 
Nave Security, Charlotte, NC; OmniNano Pharmaceuticals LLC, Houston, 
TX; OncoSenX, Seattle, WA; PatientLink Enterprises, Inc., Oklahoma 
City, OK; Perimeter Medical Imaging Corp., Dallas, TX; Radyus Research, 
Inc., Atlanta, GA; Regents of the University of Michigan, Ann Arbor, 
MI; Regents of the University of Minnesota, Minneapolis, MN; 
Saltusbiotech, Pleasanton, CA; Sama Therapeutics, Inc., Cambridge, MA; 
Sky Solutions LLC, Herndon, VA; Smart Information Flow Technologies 
LLC, Minneapolis, MN; Society of Physician Entrepreneurs, South 
Norwalk, CT; Solving MS, Edmonds, WA; Southern Methodist University, 
Dallas, TX; Syncoro Health LLC, Northville, MI; The Innovation 
Foundation at Oklahoma State University, Inc., Stillwater, OK; The Ohio 
State University, Columbus, OH; Third Pole, Inc., Waltham, MA; Tranquil 
Clinical Research, Webster, TX; Triton Systems, Inc., Chelmsford, MA; 
University of Connecticut, Storrs, CT; University of Maryland, 
Baltimore, Baltimore, MD; University of South Florida Institute of 
Applied Engineering, Inc., Tampa, FL; Virginia Commonwealth University 
Massey Comprehensive Cancer Center, Richmond, VA; Visilant, Baltimore, 
MD; and XR 2 LEAD LLC, Dumfries, VA have been added as parties to this 
venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and the CX Hub intends to file 
additional written notifications disclosing all changes in membership.
    On January 11, 2024, the CX Hub filed its original notification 
pursuant to section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to section 6(b) of 
the Act on April 16, 2024 (89 FR 26929).
    The last notification was filed with the Department on July 3, 
2024. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on September 26, 2024 (89 FR 78902).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-28196 Filed 11-29-24; 8:45 am]
BILLING CODE 4410-11-P
```